BROWN UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1764-01-01

Employees: 1K

Market Cap: -

Website: http://www.brown.edu

Clinical Trials

Pharmacy Home Adherence Reporting and Monitoring Outcomes Study

Not Applicable

Completed

Conditions: Diabetes
Hypertension
Hypercholesterolemia

Interventions: Behavioral: Pharmacist calls patient unless physician cancels call
Behavioral: Patient nonadherence information sent to physician
Behavioral: Doctor receives information and may be allowed certain actions
Behavioral: Pharmacist calls patient if physician requests call

First Posted Date: 2014-12-03

Last Posted Date: 2022-01-11

Lead Sponsor: Brown University

Target Recruit Count: 2697

Registration Number: NCT02306122

Locations: 🇺🇸
Brown University, Providence, Rhode Island, United States

Developing a Low-Intensity Primary Care Intervention for Anxiety Disorders

Not Applicable

Completed

Conditions: Anxiety Disorders

Interventions: Behavioral: Attention & Interpretation Modification

First Posted Date: 2014-10-17

Last Posted Date: 2018-01-23

Lead Sponsor: Brown University

Target Recruit Count: 14

Registration Number: NCT02266446

Locations: 🇺🇸
Family Care Center of Memorial Hospital of Rhode Island, Pawtucket, Rhode Island, United States

Vincristine Sulfate Liposome Injection (Marqibo®), Bendamustine and Rituximab-Phase I Trial in Indolent B-cell Lymphoma

Phase 1

Completed

Conditions: Lymphoma, Mantle-Cell
Lymphoma, Small-Cell
Waldenstrom Macroglobulinemia
Lymphoma, B-Cell, Marginal Zone
Lymphoma, Non-Hodgkin
Lymphoma, Follicular

Interventions: Drug: Rituximab
Drug: Bendamustine
Drug: Vincristine sulfate liposome injection

First Posted Date: 2014-10-06

Last Posted Date: 2023-02-09

Lead Sponsor: Brown University

Target Recruit Count: 11

Registration Number: NCT02257242

Locations: 🇺🇸
Rhode Island Hospital and The Miriam Hospital, Providence, Rhode Island, United States

Mifepristone for the Prevention of Relapses of Alcohol Drinking

Phase 1

Completed

Conditions: Alcohol Use Disorders (AUD)

Interventions: Drug: Mifepristone 600-mg/day or placebo for a week

First Posted Date: 2014-09-18

Last Posted Date: 2023-06-01

Lead Sponsor: Brown University

Target Recruit Count: 32

Registration Number: NCT02243709

Locations: 🇺🇸
Center for Alcohol and Addiction Studies, Brown University, Providence, Rhode Island, United States

Project 3, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in People With Current Affective Disorders

Phase 1

Completed

Conditions: Tobacco Use Disorder

Interventions: Other: Very low nicotine content cigarettes

First Posted Date: 2014-09-05

Last Posted Date: 2022-12-07

Lead Sponsor: Brown University

Target Recruit Count: 775

Registration Number: NCT02232737

Locations: 🇺🇸
Brown University, Providence, Rhode Island, United States
🇺🇸
University of Vermont, Burlington, Vermont, United States

Neurophysiologic Maturation Index for Moderate and Late Preterm Infants

Conditions: Neurophysiologic Maturation

Interventions: Other: Amplitude integrated electroencephalogram, Cardiorespiratory signal acquisition

First Posted Date: 2014-06-05

Last Posted Date: 2014-06-05

Lead Sponsor: Brown University

Target Recruit Count: 171

Registration Number: NCT02156817

Locations: 🇨🇦
McGill University Health Center, Montreal, Quebec, Canada
🇺🇸
Wayne State University, Detroit, Michigan, United States
🇺🇸
Brown University - Women and Infants Hospital of Rhode Island NICU, Providence, Rhode Island, United States

Skills to Enhance Positive Affect in Suicidal Adolescents

Not Applicable

Completed

Conditions: Suicide, Attempted
Suicidal Ideation

Interventions: Behavioral: Treatment as Usual
Behavioral: Positive Affect Skills Training

First Posted Date: 2014-05-05

Last Posted Date: 2019-03-05

Lead Sponsor: Brown University

Target Recruit Count: 52

Registration Number: NCT02130583

Locations: 🇺🇸
Butler Hospital, Providence, Rhode Island, United States

BrUOG 292: FOLFOX-A For Metastatic Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial

Phase 2

Completed

Conditions: Metastatic Pancreatic Cancer

Interventions: Drug: FOLFOXA

First Posted Date: 2014-03-06

Last Posted Date: 2022-08-01

Lead Sponsor: Brown University

Target Recruit Count: 50

Registration Number: NCT02080221

Locations: 🇺🇸
Lifespan Hospitals (The Miriam and RI Hospital, East Greenwich, Newport), Providence, Rhode Island, United States
🇺🇸
Southcoast centers for cancer care, Fairhaven, Massachusetts, United States

Neoadjuvant Gemcitabine and Fractionated, Weekly Cisplatin For Muscle Invasive Bladder Cancer and Patients Not Candidates For High Dose Cisplatin

Phase 2

Terminated

Conditions: Invasive Bladder Cancer
Bladder Cancer

Interventions: Drug: Gemcitabine and fractionated cisplatin (combination treatment)

First Posted Date: 2014-01-08

Last Posted Date: 2016-08-24

Lead Sponsor: Brown University

Target Recruit Count: 2

Registration Number: NCT02030574

Locations: 🇺🇸
Rhode Island Hospital (including Newport Hospital and East Greenwich), Providence, Rhode Island, United States
🇺🇸
The Miriam Hospital, Providence, Rhode Island, United States

BrUOG 295: Adjuvant FOLFOX-A For Resected Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial

Phase 2

Completed

Conditions: Pancreatic Cancer

Interventions: Drug: FOLFOXA

First Posted Date: 2013-12-27

Last Posted Date: 2022-06-01

Lead Sponsor: Brown University

Target Recruit Count: 25

Registration Number: NCT02022033

Locations: 🇺🇸
Roxanne Wood, Providence, Rhode Island, United States
🇺🇸
The Miriam Hospital, Providence, Rhode Island, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy